mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |